Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Warner Chilcott, Sanofi Amend Actonel Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Warner Chilcott, Sanofi Amend Actonel Pact

Warner Chilcott and Sanofi-Aventis have amended their Actonel global collaboration agreement regarding the U.S. and Puerto Rico.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Warner Chilcott and Sanofi-Aventis have amended their Actonel global collaboration agreement regarding the U.S. and Puerto Rico. Warner Chilcott will take full operational control for the promotion, marketing and R&D decisions for Actonel in the U.S. and PR, and will assume responsibility for all related costs. Warner Chilcott previously shared these costs with SA in these territories. In return, SA will receive collaboration payments based on U.S. and PR sales for the remainder of the collaboration agreement, which is set to expire at the end of 2014.

“The amendment to the collaboration agreement will enable Warner Chilcott to assume full control over the promotion and marketing of the Actonel brand in the U.S.,” stated Roger Boissonneault, president and chief executive officer of Warner Chilcott.”This will allow us improved flexibility to adjust our promotional plans in the U.S. as we prepare for the potential launch of the next generation Actonel product.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters